Dynamic glucose enhanced (DGE) MRI has shown potential for imaging D-glucose delivery and brain uptake at fields of 7T and higher. Here we evaluate some issues involved with translating DGE MRI to the clinical field strength of 3T. Due to the reduced effect size subject motion becomes more confounding than at 7T, possibly producing artifacts in terms of dynamic signal changes that are beyond the magnitude of the actual effect size. On the other hand, physiological changes such as ventricular swelling and vascular dilatation may appear as motion to the motion correction procedure, possibly leading to unintended overcorrection.
This abstract and the presentation materials are available to members only; a login is required.